Phase I Clinical Trial Success of Individualised Immunotherapies

Time: 2:30 pm
day: Track B - Day 1 PM

Details:

  • Developing individualised immunotherapy based on advanced genetic engineering and artificial intelligence (AI) technologies
  • Exploiting the mechanisms of the immune response to enable patients to defend themselves against cancer

Speakers: